LAVA Therapeutics Announces the Appointment of Dr. Charles ...

Dr. Charles Morris has joined LAVA as chief medical officer effective February 6, 2023. Dr. Morris will replace Benjamin Winograd, MD, PhD.

LAVA Therapeutics Announces the Appointment of Dr. Charles

LAVA Therapeutics Announces the Appointment of Dr. Charles Morris as Chief Medical Officer. February 06, 2023 07:00 ET | Source: LAVA Therapeutics N.V.

LAVA Therapeutics Appoints Dr. Charles Morris As Chief Medical ...

Immuno-oncology company LAVA Therapeutics N.V. (LVTX) announced Monday that Dr. Charles Morris has joined LAVA as chief medical officer ...

LAVA Therapeutics (LVTX) Announces the Appointment of Dr ...

... of Dr. Charles Morris as Chief Medical Officer. February 6, 2023 7:01 AM. LAVA Therapeutics N.V. (Nasdaq LVTX), an immuno-oncology company focused on ...

LAVA Therapeutics Appoints Dr. Charles Morris As Chief Medical ...

(RTTNews) - Immuno-oncology company LAVA Therapeutics N.V. (LVTX) announced Monday that Dr. Charles Morris has joined LAVA as chief medical ...

LAVA Therapeutics Announces Appointment of New Directors to the ...

Dr. Peter Kiener is an industry veteran with extensive experience in both biologics and immunotherapy, and biopharmaceutical research and ...

Form 6-K for Lava Therapeutics NV filed 02/06/2023

LAVA Therapeu cs Announces the Appointment of Dr. Charles Morris as Chief Medical Officer. UTRECT, The Netherlands and PHILADELPHIA, February ...

Charles Morris, MBChB, MRCP - Lava Therapeutics

Most recently, Dr. Morris was chief medical officer for Celyad Oncology, a CAR-T focused cell therapy company. In other CMO roles with Radius Health ...

LAVA Therapeutics Announces Selection by Janssen of Lead ...

LAVA Therapeutics Announces Appointment ... LAVA Therapeutics Announces the Appointment of Dr. ... Charles Morris has joined LAVA as chief medical officer effective ...

LAVA Therapeutics N.V. (LVTX) Leadership & Management Team ...

LAVA Therapeutics N.V. Announces the Appointment of Dr. Charles Morris as Chief Medical Officer. Feb 07. LAVA Therapeutics N.V. Announces Board Changes. Jan 07 ...

LAVA Therapeutics NV Stock News (LVTX) - Page 2 - Public.com

LAVA Therapeutics Announces the Appointment of Dr. Charles Morris as Chief Medical Officer. GlobeNewsWire • 02/06/23. LAVA Therapeutics to Present LAVA-1207 ...

Radius Health Appoints Dr. Charles Morris as Chief Medical Officer

04, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius" or the "Company") (Nasdaq: RDUS) today announced the appointment of Dr. Charles ...

Lava Therapeutics announces initial data from Phase 1/2a study of ...

LAVA Therapeutics Announces the Appointment of Dr. Charles Morris as Chief Medical Officer · Lava Therapeutics appoints Charles Morris as CMO ...

Insiders LAVA Therapeutics NV - LVTX Stock - MarketScreener

Lava Therapeutics Appoints New Chief Medical Officer. 06/23/06 MT. LAVA Therapeutics N.V. Announces the Appointment of Dr. Charles Morris as Chief Medical ...

LVTX SEC Filings - LAVA Therapeutics N.V.- Annual Report, Proxy ...

2023-02-06, LAVA Therapeutics Announces the Appointment of Dr. Charles Morris as Chief Medical Officer). 2023-01-09, Legal Disclosure: Forward - looking ...

LAVA Therapeutics N.V. (LVTX) Stock Price, Quote & News

LAVA Therapeutics Announces the Appointment of Dr. Charles Morris as Chief Medical Officer. UTRECT, The Netherlands and PHILADELPHIA, Feb. 06, 2023 (GLOBE ...

Sitemap LVTX News | Stock Titan

... LAVA Therapeutics Announces the Appointment of Dr. Charles Morris as Chief Medical Officer LAVA Therapeutics to Present LAVA-1207 Clinical Data at the 2023 ...

Form 6-K for Lava Therapeutics NV filed 06/15/2023

Appointment of the external auditor for the financial year ... Charles Morris, LAVA's Chief Medical Officer, added, “We are excited ...

Lava Therapeutics announces appointment of Oliger to board of ...

LAVA Therapeutics announced the appointment of Christy Oliger to its board of directors effective March 9, 2023.

LAVA Therapeutics Provides Updates on Clinical Programs and ...

... announced its decision to rationalize its pipeline and prioritize its lead solid tumor program. ... Charles Morris, LAVA's Chief Medical Officer, ...